• Nachrichtendetail
• 

18.06.2024 14:05:04 - dpa-AFX: *LIGAND SAYS MERCK RECEIVES FDA APPROVAL FOR PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE FOR ADULTS

	Name	WKN	Börse	Kurs	Datum/Zeit	Diff.	Diff. %	Geld	Brief	Erster	Schluss
	MERCK CO. DL-,01	A0YD8Q	Frankfurt	118,000	29.07.24 18:05:08	+2,000	+1,72%	117,600	117,800	115,600	116,000
	LIGAND PHARMAC.NEW DL-001	A1C9RN	Frankfurt	98,500	29.07.24 15:57:18	±0,000	±0,00%	98,500	99,500	98,500	98,500